MSB 7.69% $1.19 mesoblast limited

Ann: Day 180 Survival Outcomes In aGvHD Phase 3 Trial, page-56

  1. 1,263 Posts.
    lightbulb Created with Sketch. 73
    Well done to Meso on these results. Fantastic effort to get a phase III trial to this stage
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.